| | Genes differently expressed in oocytes matured | | in vitro or in vivo [27] | | Significantly up-regulated genes in oocytes matured in vitro | Significantly down-regulated genes in oocytes matured in vitro |
| HNRNPA2B1, TCEB1, HINT1, PNPLA1, PAOX, NLRP12, KIF23, PRPF38B, UBA52, GEM, MBD4, MORF4L2, ATF2, AFF4, ZCCHC14, ZNF669, CCNG2, NFE2L2, MSH2 *, ZNF610, C21orf66, CDC37L1, UPF3B, TAOK3, GPR64, HSPA14, C18orf24, TAF1A, MAP2K7, ZNF571, PFKFB2, CUL1, CLDN10, CLK1, RCOR1, ZPBP2, GTF2H2, TSG101, ARHGAP11A, HPS3, GRHL1, EIF4G2, RFC4, VPS26A, PIK3C2A, GDI2, RAB23, WDSOF1, PLCL1, DCDC2, MINPP1, PTPN12, METAP2, LHX8, LOC91664,
SYCP2 *, ATP5L, ICK, FUCA1, SMARCAD1, BRD7, TBPL1, ABCD3, SSR3, FEZ2, FHOD3, AMD1, DAZL *, ZMYM2, FANCL, SLCO1A2, NUFIP1, STAU2, PCF11, PPP1R3C, POLI, SGOL2 *, PBLD, CCNL1, SLBP, MRPS30, TMOD2, FBXW11, CDK7, HNRNPR, CFDP1, DEPDC7, CTSL2, DYNC1I2, NCKAP1, TRPA1, DCLRE1A, RAB18, GTDC1, LOC283514, CLUL1, ZNF131, SP3, ZNF302, MAD2L1, TRAPPC6B, C10orf137, MTPN, ZNF313, PLEKHA3, ZCCHC14, RTTN, ZNF136, ADH5, CCDC88A, CPEB2, SPATA5L1, UGP2, UGP2,MFSD1, TMEM27, ZNF443, UAP1, MIB1, MUT | HTRA1, CCDC69, FHL2 |
| | Molecular functions of differently expressed genes | | (in vitro versus in vivo matured oocytes) [26] | Significantly up-regulated genes in
oocytes matured in vitro (number) | Significantly down-regulated genes in oocytes matured in vitro (number) |
| | (i) Nucleic acid binding (62) | (i) Nucleic acid binding (75) | | (ii) Zinc finger transcription factor (13) | (ii) Ribosomal protein (37) | | (iii) Other RNA-binding factors (10) | (iii) Translation factor (8) | | (iv) Ligase (9) | (iv) Translation elongation factor (6) | | (v) KRAB box transcription factor (8) | (v) Storage protein (6) | | (vi) mRNA processing factor (8) | (vi) Receptor (5) | | (vii) Chaperone (7) | (vii) Tubulin (4) | | (viii) Receptor (7) | (viii) Signaling molecule (3) | | (ix) Signaling (7) | (ix) Ribonucleoprotein (2) | | (x) Ribonucleoprotein (7) | (x) Defense/immunity protein (1) |
|
|
